141 related articles for article (PubMed ID: 7495809)
1. Analysis of the proteolytic activity of a recombinant form of apolipoprotein(a).
Gabel BR; Koschinsky MI
Biochemistry; 1995 Dec; 34(48):15777-84. PubMed ID: 7495809
[TBL] [Abstract][Full Text] [Related]
2. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
3. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
4. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
Edelstein C; Italia JA; Scanu AM
J Biol Chem; 1997 Apr; 272(17):11079-87. PubMed ID: 9111002
[TBL] [Abstract][Full Text] [Related]
5. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
[TBL] [Abstract][Full Text] [Related]
6. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein.
Frank S; Krasznai K; Durovic S; Lobentanz EM; Dieplinger H; Wagner E; Zatloukal K; Cotten M; Utermann G; Kostner GM
Biochemistry; 1994 Oct; 33(40):12329-39. PubMed ID: 7918455
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
Liu L; Boffa MB; Koschinsky ML
PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
[TBL] [Abstract][Full Text] [Related]
9. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
Klezovitch O; Scanu AM
Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):392-8. PubMed ID: 8630665
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.
Sangrar W; Bajzar L; Nesheim ME; Koschinsky ML
Biochemistry; 1995 Apr; 34(15):5151-7. PubMed ID: 7711034
[TBL] [Abstract][Full Text] [Related]
11. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
12. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
[TBL] [Abstract][Full Text] [Related]
13. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
14. Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site.
Hervio L; Brunner C; Sorell L; Kang C; Müller H; Anglés-Cano E
Biochim Biophys Acta; 1999 Sep; 1434(1):124-34. PubMed ID: 10556566
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic degradation of low-density lipoprotein by lipoprotein(a) and by recombinant apo(a).
Pursiainen M; Jauhiainen M; Kovanen PT; Ehnholm C
Chem Phys Lipids; 1994 Jan; 67-68():25-33. PubMed ID: 8187221
[TBL] [Abstract][Full Text] [Related]
16. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
17. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
Eaton DL; Fless GM; Kohr WJ; McLean JW; Xu QT; Miller CG; Lawn RM; Scanu AM
Proc Natl Acad Sci U S A; 1987 May; 84(10):3224-8. PubMed ID: 3472206
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation.
Gabel BR; May LF; Marcovina SM; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1559-67. PubMed ID: 8977462
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells.
Koschinsky ML; Tomlinson JE; Zioncheck TF; Schwartz K; Eaton DL; Lawn RM
Biochemistry; 1991 May; 30(20):5044-51. PubMed ID: 2036372
[TBL] [Abstract][Full Text] [Related]
20. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
